AVITA Medical (RCEL) Revenue Growth (3y) (2021 - 2025)
AVITA Medical (RCEL) Revenue Growth (3y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 5.28% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 10.52% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.73% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 17.14% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 2.92% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 7.43% |
| 10 | AVITA Medical | 109.91 Mn | 91.73 Mn | 14.31 Mn | 113.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 113.49% |
| Sep 30, 2025 | 23.35% |
| Mar 31, 2025 | 34.92% |
| Sep 30, 2024 | 40.32% |
| Jun 30, 2024 | 13.82% |
| Mar 31, 2024 | 8.20% |
| Dec 31, 2023 | 40.64% |
| Sep 30, 2023 | 39.19% |
| Jun 30, 2023 | 44.73% |
| Mar 31, 2023 | 39.61% |
| Dec 31, 2022 | 42.62% |
| Sep 30, 2022 | 40.90% |
| Mar 31, 2022 | 63.97% |
| Sep 30, 2021 | 196.62% |